Hospice and neurological rehabilitation charity Sue Ryder estimates that a lack of dedicated neurological care and rehabilitation services in Scotland means that up to 1,000 people are being cared for in inappropriate settings.
Researchers have reported that people drinking more than 900 ml of coffee each day, roughly equivalent to three average-size mugs, are up to 30% less likely to develop multiple sclerosis than people who drink no coffee.
Recommendations from the EMA to reduce the risk of PML for those at high risk taking the multiple sclerosis disease modifying drug Tysabri (natalixzumab) suggest increasing the frequency of MRI scans.
Last week the Public Accounts Committee has published its report into services for people with neurological conditions. The report by the influential parliamentary committee recognises the ongoing challenges facing neurology services finding that, despite a similar review in 2012, there is still “wide variation across the country in access, outcomes and patient experience.”
The MS-SMART trial will look at drugs that may limit the progression of MS. Researchers have been recruiting people with secondary progressive MS from across the UK, but are still in need of more people to volunteer to take part.
Ozanimod is a drug that works in a similar way to Gilenya (fingolimod) but with fewer side effects according to recently published research.
Ocrelizumab has become the first new medicine for MS to be granted a special status that could speed up approval by the American drug regulators
Results of a small study just published suggest that the epilepsy drug phenytoin may have a neuroprotective effect and could potentially be beneficial in people with MS.
Last night (Monday 18 January 2016) you may have seen that BBC1 broadcast an episode of Panorama called “Can you stop my multiple sclerosis?”. The programme explored the use of stem cell therapy at Sheffield Teaching Hospitals to treat people with multiple sclerosis. The MS Trust was glad that the programme took a considered, unsensationalist approach to what has sometimes proved to be a controversial issue.